1. Home
  2. AEMD vs ITOC Comparison

AEMD vs ITOC Comparison

Compare AEMD & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

BUY

Current Price

$5.86

Market Cap

4.3M

Sector

Health Care

ML Signal

BUY

ITOC

iTonic Holdings Ltd Class A Ordinary Shares

BUY

Current Price

$3.58

Market Cap

5.0M

Sector

N/A

ML Signal

BUY

Company Overview

Basic Information
Metric
AEMD
ITOC
Founded
1984
1998
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
5.0M
IPO Year
2008
2023

Fundamental Metrics

Financial Performance
Metric
AEMD
ITOC
Price
$5.86
$3.58
Analyst Decision
Hold
Analyst Count
2
0
Target Price
★ $13.25
N/A
AVG Volume (30 Days)
★ 2.4M
745.5K
Earning Date
11-11-2026
03-19-2027
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.53
$0.22
52 Week High
$35.97
$4.49

Technical Indicators

Market Signals
Indicator
AEMD
ITOC
Relative Strength Index (RSI) 58.98 81.94
Support Level $3.20 $0.27
Resistance Level $6.69 N/A
Average True Range (ATR) 0.34 0.20
MACD -0.14 0.41
Stochastic Oscillator 0.89 79.06

Price Performance

Historical Comparison
AEMD
ITOC

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

About ITOC iTonic Holdings Ltd Class A Ordinary Shares

iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.

Share on Social Networks: